These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 22531510)

  • 1. Transcriptome network analysis reveals candidate genes for renal cell carcinoma.
    Zhai W; Xu YF; Liu M; Zheng JH
    J Cancer Res Ther; 2012; 8(1):28-33. PubMed ID: 22531510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal gene expression profile reveals the common key signatures associated with clear cell renal cell carcinoma: a meta-analysis.
    Zhang HJ; Sun ZQ; Qian WQ; Sheng L
    Genet Mol Res; 2015 Mar; 14(1):2216-24. PubMed ID: 25867368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression analysis of the estrogen receptor target genes in renal cell carcinoma.
    Liu Z; Lu Y; He Z; Chen L; Lu Y
    Mol Med Rep; 2015 Jan; 11(1):75-82. PubMed ID: 25351113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway.
    Yamasaki T; Seki N; Yoshino H; Itesako T; Hidaka H; Yamada Y; Tatarano S; Yonezawa T; Kinoshita T; Nakagawa M; Enokida H
    J Urol; 2013 Sep; 190(3):1059-68. PubMed ID: 23454155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of key genes and pathways in renal cell carcinoma through expression profiling data.
    Liu X; Wang J; Sun G
    Kidney Blood Press Res; 2015; 40(3):288-97. PubMed ID: 26043775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microarray profiling of human renal cell carcinoma: identification for potential biomarkers and critical pathways.
    Li W; Zhu W; Che J; Sun W; Liu M; Peng B; Zheng J
    Kidney Blood Press Res; 2013; 37(4-5):506-13. PubMed ID: 24247930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of genes and pathways involved in kidney renal clear cell carcinoma.
    Yang W; Yoshigoe K; Qin X; Liu JS; Yang JY; Niemierko A; Deng Y; Liu Y; Dunker A; Chen Z; Wang L; Xu D; Arabnia HR; Tong W; Yang M
    BMC Bioinformatics; 2014; 15 Suppl 17(Suppl 17):S2. PubMed ID: 25559354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identified differently expressed genes in renal cell carcinoma by using multiple microarray datasets running head: differently expressed genes in renal cell carcinoma.
    Cheng Y; Hong M; Cheng B
    Eur Rev Med Pharmacol Sci; 2014; 18(7):1033-40. PubMed ID: 24763884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
    Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ
    BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening of feature genes of the renal cell carcinoma with DNA microarray.
    Feng JY; Diao XW; Fan MQ; Wang PX; Xiao Y; Zhong X; Wu RH; Huang CB
    Eur Rev Med Pharmacol Sci; 2013 Nov; 17(22):2994-3001. PubMed ID: 24302177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 44-gene set constructed for predicting the prognosis of clear cell renal cell carcinoma.
    Wang Y; Wang Y; Liu F
    Int J Mol Med; 2018 Dec; 42(6):3105-3114. PubMed ID: 30272265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of human prolactinoma related genes by DNA microarray.
    Zhao L; Lin M; Wang S
    J Cancer Res Ther; 2014; 10(3):544-8. PubMed ID: 25313736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the mechanism of clear cell renal cell carcinoma metastasis and key genes based on multi-tool joint analysis.
    Yang H; Li W; Lv Y; Fan Q; Mao X; Long T; Xie L; Dong C; Yang R; Zhang H
    Gene; 2019 Dec; 720():144103. PubMed ID: 31491435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of S100A8 expression on kidney cancer progression and molecular docking studies for kidney cancer therapeutics.
    Mirza Z; Schulten HJ; Farsi HM; Al-Maghrabi JA; Gari MA; Chaudhary AG; Abuzenadah AM; Al-Qahtani MH; Karim S
    Anticancer Res; 2014 Apr; 34(4):1873-84. PubMed ID: 24692722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive analysis of Wnt/β-catenin signaling pathway-related genes and crosstalk pathways in the treatment of As
    Li YL; Jin YF; Liu XX; Li HJ
    Ren Fail; 2018 Nov; 40(1):331-339. PubMed ID: 29633893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of EGFR as a Novel Key Gene in Clear Cell Renal Cell Carcinoma (ccRCC) through Bioinformatics Analysis and Meta-Analysis.
    Wang S; Yu ZH; Chai KQ
    Biomed Res Int; 2019; 2019():6480865. PubMed ID: 30895194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene signatures of progression and metastasis in renal cell cancer.
    Jones J; Otu H; Spentzos D; Kolia S; Inan M; Beecken WD; Fellbaum C; Gu X; Joseph M; Pantuck AJ; Jonas D; Libermann TA
    Clin Cancer Res; 2005 Aug; 11(16):5730-9. PubMed ID: 16115910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Landscape of expression profiles in esophageal carcinoma by The Cancer Genome Atlas data.
    Zhan C; Yan L; Wang L; Jiang W; Zhang Y; Xi J; Jin Y; Chen L; Shi Y; Lin Z; Wang Q
    Dis Esophagus; 2016 Nov; 29(8):920-928. PubMed ID: 26402921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcription profiling of renal cell carcinoma.
    Huber W; Boer JM; von Heydebreck A; Gunawan B; Vingron M; Füzesi L; Poustka A; Sültmann H
    Verh Dtsch Ges Pathol; 2002; 86():153-64. PubMed ID: 12647365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of T cell factor 4 in renal cell carcinoma].
    Lin G; Zang T; Zhang Z; Xing D; Guo Y
    Zhonghua Wai Ke Za Zhi; 2000 Jun; 38(6):460-1. PubMed ID: 11832085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.